Por: Ars Technica Science September 26, 2023
Navigate Filter by topic Settings Front page layout Site theme - Sep 26, 2023 6:20 pm UTC / A decent placebo setup for transcranial magnetic stimulation is difficult to distinguish from actual treatment. Placebos have occupied an increasingly awkward spot in the medical landscape over the last few decades. Even as placebo-controlled trials have become accepted as the gold standard for evidence, we've grown to appreciate just how powerful... + full article
RTTNews USA Health August 22, 2023
The U.S. Food and Drug Administration announced the approval of Pfizer Inc.'s Abrysvo (Respiratory Syncytial Virus Vaccine) for use in pregnant individuals to prevent respiratory syncytial virus or RSV in infants.It is the first vaccine approval for use in pregnant... + más
FDA approves first RSV vaccine for pregnancy to protect newborns | CBS News
First RSV vaccine to protect infants wins backing of FDA panel | CBS News
The Boston Globe USA Business July 21, 2023
Neumora, a privately held biotech company based in Watertown, is moving into the final phase of testing with a novel treatment for depression that showed promise in a mid-stage trial.The drug, a daily pill called navacaprant, led to statistically significant improvements over... + más
Not far from Kendall Square, Watertown emerges as a biotech hub | The Boston Globe
Watertown has been a city for decades. Now, it’s acting like one. | The Boston Globe
ABC News USA Health June 29, 2023
Researchers in Australia have found that for low back pain sufferers in their mid-40s, opioids don’t mitigate pain any better than a placebo. Among the study’s participants, the placebo gave slightly more positive results in helping manage pain.Close to 350 participants –... + más
High school scores and top performers from Friday, March 24 | Orlando Sentinel
High school scores and top performers from Tuesday, March 28 | Orlando Sentinel
ABC7 USA World June 29, 2023
. Recruited through primary care clinics and emergency departments, the study participants were randomly assigned either an opioid or placebo to treat lower back pain or neck pain.Across the six-week treatment period, there was no difference in the pain levels reported by the... + más
Opioids are no better than a placebo for back pain: Study | ABC News
The Boston Globe USA Nation December 29, 2022
A new coronavirus variant dubbed XBB has swiftly spreading in the Northeast, jumping from about 35 percent of cases during the week ending Dec. 17 to just over half of cases last week, according to .Here’s a quick primer on what we know about the variant.It is more... + más
Highly Immune Evasive Omicron XBB.1.5 Variant Is Quickly Becoming Dominant in U.S. as It Doubles Weekly | NBC 6 South Florida
Highly immune evasive omicron XBB.1.5 variant is quickly becoming dominant in U.S. as it doubles weekly | CNBC
The New York Times USA Health November 09, 2022
Over the course of the Covid-19 pandemic, rates of depression and anxiety , and many Americans turned to antidepressant medication to help them cope. Even before the emergence of Covid, was taking an antidepressant drug. According to one estimate, that number during 2020. Zoloft... + más
Russians turning to antidepressants as drug sales soar | Newsweek
Meghan Trainor Says Nurses Made Her Feel Bad for Taking Antidepressants While Pregnant | NBC 6 South Florida
RTTNews USA Health October 03, 2022
Biopharmaceutical company Axsome Therapeutics, Inc. () announced Monday that Sunosi met the primary endpoint in the SHARP study and significantly improved cognitive function, measured using the Digit Symbol Substitution Test subtest of the Repeatable Battery for the Assessment... + más
Kandji announces new Device Harmony platform to streamline Mac IT and infosec operations | 9to5Mac
Auvelity, Newly Approved Drug For Major Depressive Disorder, To Face Payer Pricing And Reimbursement Challenges | Forbes
About iurex | Privacy Policy | Disclaimer |